ICU · Respiratory
Refractory hypoxaemia and rescue therapies for severe ARDS
Also known as Refractory hypoxaemia · Difficult-to-ventilate ARDS · Rescue therapies for severe ARDS · ECMO for refractory respiratory failure · Prone positioning · Inhaled pulmonary vasodilators · Recruitment manoeuvres · ECCO2R
Refractory hypoxaemia describes persistent, life-threatening hypoxaemia (PaO2/FiO2 <100) despite optimised conventional lung-protective ventilation — Vt 6 mL/kg PBW with plateau pressure <30 (ARDSNet), PEEP ≥5 cmH2O and FiO2 ≥0.6 (the PROSEVA definition of severe ARDS). It demands stepwise, protocolised escalation through rescue therapies: (1) re-optimise ventilation and treat reversible causes; (2) prone positioning for ≥16 hours/day (PROSEVA — 28-day mortality 16.0% vs 32.8%); (3) neuromuscular blockade for severe dyssynchrony (ACURASYS benefit vs ROSE no benefit); (4) inhaled pulmonary vasodilators (low-concentration nitric oxide or inhaled epoprostenol) as a transient bridge; (5) recruitment manoeuvres and higher-PEEP strategy (Briel meta-analysis — benefit in ARDS with P/F ≤200); (6) permissive hypercapnia (accept the CO2 that lung protection produces); (7) ECCO2R to enable ultra-protective ventilation; (8) veno-venous ECMO (CESAR, EOLIA) as a bridge to recovery or decision. The cardinal rule: do NOT persist with a failing strategy — each step has a time window measured in hours, not days.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- PaO2/FiO2 <80 despite optimised ventilation = activate the ECMO pathway
- Do NOT persist with a failing ventilation strategy — escalate EARLY, in hours not days
- Hypercapnia with pH <7.25 and PaCO2 ≥60 mmHg for >6 h despite lung-protective ventilation = consider ECCO2R or VV-ECMO (EOLIA escalation criteria)
- Rising driving pressure is the ventilation variable most strongly linked to mortality (Amato) — reduce Vt, do not chase oxygenation with injurious settings
- Prolonged high-pressure ventilation is a relative ECMO contraindication — refer early, before a fibrotic phase develops
- Permissive hypercapnia is contraindicated in raised intracranial pressure — CO2-mediated vasodilation raises ICP
Definition
Refractory hypoxaemia is persistent, life-threatening arterial hypoxaemia (classically PaO2/FiO2 under 100 — severe ARDS by the Berlin definition — and often under 80) that persists despite optimised conventional lung-protective mechanical ventilation.[17][16][14] The term is reserved for the patient in whom the baseline therapy has been correctly applied and exhausted, signalling the need for rescue (salvage) therapies. It is a problem-oriented descriptor rather than a distinct disease — the underlying pathology is almost always severe ARDS (most commonly from pneumonia, aspiration, sepsis, or trauma), occasionally compounded by pulmonary vascular shunting, severe atelectasis, or unrecognised concurrent processes (pneumothorax, pleural effusion, mucus plugging, endobronchial intubation, RV failure, large PE).
Diagnostic threshold and prerequisite checklist
The label "refractory" should only be applied once all of the following have been confirmed — otherwise you risk escalating over a fixable problem:[16][3]
| Domain | Requirement before declaring refractory |
|---|---|
| Tidal volume | Vt **6 mL/kg predicted body weight** (ARDSNet target; mean achieved 6.2 mL/kg PBW) |
| Plateau pressure | **Under 30 cmH2O**, measured after a 0.5-second inspiratory pause (the ARDSNet method) |
| Driving pressure (ΔP) | Minimise **ΔP** — the ventilation variable most strongly associated with survival; each ~7 cmH2O increment raises mortality (RR 1.41) |
| PEEP | **At least 5 cmH2O**, adequately titrated (PROSEVA defined severe ARDS at PEEP at least 5 with FiO2 at least 0.6) |
| FiO2 | **At least 0.6** — the PROSEVA severity threshold; a higher FiO2 exposes the true shunt burden |
| Reversible causes | **Excluded**: endotracheal tube obstruction / mucus plug, pneumothorax, pleural effusion, aspiration, ventilator dyssynchrony, untreated sepsis, deep sedation / analgesia adequate |
| Haemodynamics | Adequate cardiac output and haemoglobin (a low mixed-venous oxygen from shock worsens PaO2) |
Intrapulmonary shunt
Dominant mechanism
- Perfusion of non-ventilated alveoli — refractory to supplemental O2
- Caused by alveolar flooding (oedema), consolidation (pneumonia), atelectasis
- Target: RECRUIT alveoli (PEEP, prone, recruitment manoeuvres)
Low V/Q + dead space
Contributes to hypoxaemia + hypercapnia
- Heterogeneous injury — some units underventilated, others overventilated
- High dead-space fraction drives hypercapnia and ventilator dyssynchrony
- Target: optimise Vt/PEEP; ECCO2R removes CO2 when Vt must fall
Pulmonary vascular dysregulation
Target of inhaled vasodilators
- Hypoxic pulmonary vasoconstriction is lost/blunted in injured regions
- Blood is maldistributed toward shunted (injured) lung
- Target: inhaled NO/epoprostenol vasodilates ONLY ventilated units → diverts flow
Impaired oxygen delivery
Systemic — worsens measured hypoxaemia
- Low cardiac output or anaemia lowers mixed-venous O2 → PaO2 falls
- Shock must be treated concurrently; do not chase PaO2 alone
- Target: restore DO2 (haemoglobin, inotropes, source control)
References20ShowHide
- [2]Combes A, Hajage D, Capellier G, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome N Engl J Med, 2018.PMID 29791822
- [3]Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome N Engl J Med, 2013.PMID 23688302
- [4]Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome N Engl J Med, 2010.PMID 20843245
- [5]Moss M, Huang DT, Brower RG, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome N Engl J Med, 2019.PMID 31112383
- [6]Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial Lancet, 2009.PMID 19762075
- [7]Cavalcanti AB, Suzumura ÉA, Laranjeira LN, et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial JAMA, 2017.PMID 28973363
- [8]Amato MBP, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome N Engl J Med, 2015.PMID 25693014
- [9]Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury N Engl J Med, 2006.PMID 16714767
- [10]Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis JAMA, 2010.PMID 20197533
- [11]Gebistorf F, Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults Cochrane Database Syst Rev, 2016.PMID 27347773
- [12]Villar J, Añón JM, Ferrando C, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial Lancet Respir Med, 2020.PMID 32043986
- [13]Worku E, Brodie D, Ling RR, et al. Venovenous extracorporeal CO(2) removal to support ultraprotective ventilation in moderate-severe acute respiratory distress syndrome: A systematic review and meta-analysis of the literature Perfusion, 2023.PMID 35656595
- [14]Gorman EA, O'Kane CM, McAuley DF Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management Lancet, 2022.PMID 36070788
- [15]Scholten EL, Beitler JR, Prisk GK, et al. Treatment of ARDS With Prone Positioning Chest, 2017.PMID 27400909
- [16]Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med, 2000.PMID 10793162
- [17]Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition JAMA, 2012.PMID 22797452
- [18]Hsu CW, Lee DL, Lin SL, et al. The initial response to inhaled nitric oxide treatment for intensive care unit patients with acute respiratory distress syndrome Respiration, 2008.PMID 17396026
- [19]Buckley MS, Mendez A, Radosevich JJ, et al. Comparison of 2 different inhaled epoprostenol dosing strategies for acute respiratory distress syndrome in critically ill adults: Weight-based vs fixed-dose administration Am J Health Syst Pharm, 2023.PMID 35877207
- [20]Gendreau S, Geri G, Pham T, et al. The role of acute hypercapnia on mortality and short-term physiology in patients mechanically ventilated for ARDS: a systematic review and meta-analysis Intensive Care Med, 2022.PMID 35294565
- [21]Matin N, Sarhadi K, Crooks CP, et al. Brain-Lung Crosstalk: Management of Concomitant Severe Acute Brain Injury and Acute Respiratory Distress Syndrome Curr Treat Options Neurol, 2022.PMID 35965956